Skip to main content

Articles

Practice Management
Examining the Value of Subsidies of Health Plans and Cost-Sharing for Prescription Drugs in the Health Insurance Marketplace
Stakeholder Perspective
Health Plan Subsidies, Prescription Drugs, and Cost
Read More
Payers' Guide, FDA Approvals
Tecentriq (Atezolizumab) First PD-L1 Inhibitor Approved for Patients with Advanced or Metastatic Urothelial Carcinoma
Read More
Perspectives
Eye of the Consolidation Storm
Read More
Practice Management
Revealed Opportunism: How Physicians “Game” Prior Authorization Protocols Until They Are Rescinded
Stakeholder Perspective
A Matter of Trust
Read More
Original Research
Treatment of Chronic Hepatitis C Infection with Sofosbuvir-Based Regimens in a Commercially Insured Patient Population
Stakeholder Perspective
Evaluating the True Value of High-Cost Therapies for Hepatitis C Infection
Read More
Original Research
Evaluating Outcomes in Patients with Overactive Bladder within an Integrated Healthcare Delivery System Using a Treatment Patterns Analyzer
Stakeholder Perspective
Implications of Big Data Analysis in the Real-World Setting: The Case of Overactive Bladder Treatment
Read More
Practice Management
Employer Perspectives on a Specialty Drug Step-Therapy Program Evaluation
Read More
Perspectives
The Challenge of Balancing Access to and Paying for New, High-Cost Cancer Therapies
Read More
Leukemia, Oncology
Refining the Use of CAR T-Cells in Patients with Acute Lymphoblastic Leukemia
Read More
Leukemia, Oncology
CAR T-Cell Therapy Produces High Response Rates in Refractory B-Cell Malignancies
Read More
Page 106 of 245
Results 1051 - 1060 of 2441